Old Web
English
Sign In
Acemap
>
authorDetail
>
C Conner
C Conner
Boehringer Ingelheim
Medicine
Tenofovir
Emtricitabine
Nevirapine
Ritonavir
4
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients.
2011
International Journal of Clinical Practice
Edwin DeJesus
A. Mills
L. Bhatti
C Conner
S. Storfer
Show All
Source
Cite
Save
Citations (18)
Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
2010
Journal of the International AIDS Society
Edwin DeJesus
A. Mills
L. Bhatti
C Conner
S. Storfer
Show All
Source
Cite
Save
Citations (1)
Lipid changes in patients receiving nevirapine (NVP) in combination with tenofovir/emtricitabine: results from the CCIAT trial
2008
Journal of the International AIDS Society
Charles E. L. B. Davis
Rohit Talwani
Bruce L. Gilliam
Anthony Amoroso
C. Boyce
Peter J. Piliero
C Conner
Robert R. Redfield
Show All
Source
Cite
Save
Citations (2)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
2008
Journal of the International AIDS Society
Robert Douglas Bruce
Frederick L. Altice
David E. Moody
Shen-Nan Lin
Wenfang B. Fang
John P. Sabo
Jan M. Wruck
C Conner
Peter J. Piliero
Laurie Andrews
Gerald Friedland
Show All
Source
Cite
Save
Citations (1)
1